Comment: Pharmacy and Generic Substitution of Antiepileptic Drugs: Missing in Action?

Abstract

Get full access to this article

View all access options for this article.

References

Henney

. From the Food and Drug Administration. JAMA 1999;282:1995.

Burkhardt

Leppik

Blesi

Scott

Gapany

Cloyd

. Lower phenytoin serum levels in persons switched from brand to generic phenytoin. Neurology 2004;63:1494–6.

Mayer

May

Altenmüller

Sandmann

Wolf

. Clinical problems with generic antiepileptic drugs: comparison of sustained-release formulations of carbamazepine. Clin Drug Invest 1999;18:17–26.

Andermann

Duh

Gosselin

Paradis

. Compulsory generic switching of antiepileptic drugs: high switchback rates to branded compounds compared to other drug classes. Epilepsia 2007;48:464–9.

Tomson

Dahl

Kimland

. Therapeutic monitoring of antiepileptic drugs for epilepsy. Cochrane Database Syst Rev 2007(2):CD002216. DOI 10.1002/14651858.CD002216.pub2